Medtronic had a busy 2025. Here are nine updates for spine and orthopedic surgeons to know:
1. Medtronic acquired rights and intellectual property related to Nanovis’ Sites Medical’s OsteoSync titanium pads.
2. The company was included on Fortune’s annual list of the World’s Most Admired Companies.
3. Thierry Piéton was appointed as Medtronic’s next CFO.
4. Medtronic and Kuros Biosciences signed a strategic agreement to support sales of the MagnetOs bone graft technology.
5. Medtronic saw $8.3 billion in revenue during the third quarter of fiscal year 2025, according to financial results posted Feb. 18.
6. Medtronic launched the CD Horizon ModuLeX spinal system for deformity surgery.7. Medtronic was included on the 2025 “World’s Most Ethical” list from Ethisphere.
7. In the first quarter of fiscal year 2026, Medtronic saw growth in its overall revenue and neuroscience portfolio.
8. Ken Washington, PhD, chief technology and innovation officer at Medtronic, retired effective Nov. 14.
9. Medtronic saw 6.6% year over year growth in the second quarter of fiscal year 2026, according to financial results posted Nov. 18.
